Please assess the completion status of the following clinical trial:

Trial Title: School-Based Treatment With ACT to Reduce Transmission

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
For IPT intervention~Inclusion Criteria:~1. Student enrolled in a participating intervention school.~2. Willingness of parent/guardian to provide written informed consent.~3. Provision of written assent by the student (aged 8 years or above).~Exclusion Criteria:~1. Age \< 5 years~2. Known allergy or history of adverse reaction to DP~3. Menarche in female students~4. Weight \< 11 kg~5. History of cardiac problems or fainting~6. Family history of long QT syndrome~7. Current use of medications known to prolong the QT interval~8. Not able to locate parent or guardian, after at least three attempts including parent/teacher association (PTA) meetings and home visits~9. Not able to locate the student at school, after at least three attempts

- Gender: ALL
- Minimum Age: 5 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Intermittent preventive treatment (IPT) (Type: EXPERIMENTAL): Dihydroartemisinin-piperaquine (DP)
- Control (Type: NO_INTERVENTION): No intermittent preventive treatment (IPT) with dihyroartemisinin-piperaquine (DP) will be given.

Based on this trial design, predict the completion outcome and termination type (if applicable).